Viral Vectors in Gene Therapy
PanTherapeutics, CH1095 Lutry, Switzerland
Diseases 2018, 6(2), 42; https://doi.org/10.3390/diseases6020042
Received: 30 April 2018 / Revised: 15 May 2018 / Accepted: 16 May 2018 / Published: 21 May 2018
(This article belongs to the Special Issue Gene Therapy)
Applications of viral vectors have found an encouraging new beginning in gene therapy in recent years. Significant improvements in vector engineering, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. Viral vectors have been employed for the treatment of various diseases such as metabolic, cardiovascular, muscular, hematologic, ophthalmologic, and infectious diseases and different types of cancer. Recent development in the area of immunotherapy has provided both preventive and therapeutic approaches. Furthermore, gene silencing generating a reversible effect has become an interesting alternative, and is well-suited for delivery by viral vectors. A number of preclinical studies have demonstrated therapeutic and prophylactic efficacy in animal models and furthermore in clinical trials. Several viral vector-based drugs have also been globally approved. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Lundstrom, K. Viral Vectors in Gene Therapy. Diseases 2018, 6, 42.
AMA StyleShow more citation formats Show less citations formats
Lundstrom K. Viral Vectors in Gene Therapy. Diseases. 2018; 6(2):42.Chicago/Turabian Style
Lundstrom, Kenneth. 2018. "Viral Vectors in Gene Therapy." Diseases 6, no. 2: 42.
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Article Access Statistics
Multiple requests from the same IP address are counted as one view.